Fernando Sánchez‐Alonso

2.3k total citations
105 papers, 1.4k citations indexed

About

Fernando Sánchez‐Alonso is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Fernando Sánchez‐Alonso has authored 105 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Rheumatology, 36 papers in Immunology and 13 papers in Hematology. Recurrent topics in Fernando Sánchez‐Alonso's work include Rheumatoid Arthritis Research and Therapies (46 papers), Spondyloarthritis Studies and Treatments (23 papers) and Systemic Lupus Erythematosus Research (18 papers). Fernando Sánchez‐Alonso is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (46 papers), Spondyloarthritis Studies and Treatments (23 papers) and Systemic Lupus Erythematosus Research (18 papers). Fernando Sánchez‐Alonso collaborates with scholars based in Spain, United States and South Africa. Fernando Sánchez‐Alonso's co-authors include Javier Domı́nguez, Ángel Ezquerra, Mariano Sánchez Crespo, Belén Álvarez, Concepción Revilla, Pedro Iñarrea, Nieves Doménech, Carlos Sánchez‐Piedra, Vicente Álvarez and Sonia Chamorro and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Biochemical Journal.

In The Last Decade

Fernando Sánchez‐Alonso

98 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Sánchez‐Alonso Spain 23 504 367 199 146 138 105 1.4k
Yukië Tanaka Japan 20 317 0.6× 79 0.2× 476 2.4× 96 0.7× 245 1.8× 68 1.3k
Monika Fijak Germany 24 1.0k 2.1× 118 0.3× 363 1.8× 45 0.3× 138 1.0× 44 2.0k
Ann Marie Bongiovanni United States 24 383 0.8× 190 0.5× 329 1.7× 34 0.2× 369 2.7× 86 1.5k
H. WORSAAE Denmark 10 763 1.5× 215 0.6× 262 1.3× 82 0.6× 381 2.8× 12 1.8k
Subbi Mathur United States 29 900 1.8× 127 0.3× 252 1.3× 71 0.5× 149 1.1× 90 2.2k
Sudhanshu Bhushan Germany 26 816 1.6× 91 0.2× 421 2.1× 36 0.2× 154 1.1× 59 1.9k
Gudmund Marhaug Norway 24 128 0.3× 191 0.5× 958 4.8× 241 1.7× 152 1.1× 56 1.8k
Ilkka Junttila Finland 20 964 1.9× 134 0.4× 532 2.7× 99 0.7× 129 0.9× 47 2.0k
Guan K. Tay Australia 20 512 1.0× 61 0.2× 416 2.1× 114 0.8× 146 1.1× 81 1.5k
Sylvette Bas Switzerland 19 641 1.3× 549 1.5× 293 1.5× 200 1.4× 282 2.0× 34 1.5k

Countries citing papers authored by Fernando Sánchez‐Alonso

Since Specialization
Citations

This map shows the geographic impact of Fernando Sánchez‐Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Sánchez‐Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Sánchez‐Alonso more than expected).

Fields of papers citing papers by Fernando Sánchez‐Alonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Sánchez‐Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Sánchez‐Alonso. The network helps show where Fernando Sánchez‐Alonso may publish in the future.

Co-authorship network of co-authors of Fernando Sánchez‐Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Sánchez‐Alonso. A scholar is included among the top collaborators of Fernando Sánchez‐Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Sánchez‐Alonso. Fernando Sánchez‐Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Llorca, Javier, Iván Ferraz‐Amaro, Santos Castañeda, et al.. (2025). Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases. Seminars in Arthritis and Rheumatism. 72. 152694–152694. 3 indexed citations
2.
González‐Gay, Miguel Á., Iván Ferraz‐Amaro, Santos Castañeda, et al.. (2025). The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohort. RMD Open. 11(1). e005352–e005352. 2 indexed citations
3.
Llorca, Javier, Iván Ferraz‐Amaro, Santos Castañeda, et al.. (2025). Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort. Seminars in Arthritis and Rheumatism. 75. 152833–152833.
4.
Vela, Paloma, Sílvia Gómez, Rocío Caño, et al.. (2025). Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry. Arthritis Research & Therapy. 27(1). 103–103. 2 indexed citations
5.
López‐Medina, Clementina, Fernando Sánchez‐Alonso, Vega Jovaní, et al.. (2025). One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry. Reumatología Clínica. 21(5). 501872–501872.
6.
Calvo-Gutiérrez, J., Clementina López‐Medina, Alejandro Escudero‐Contreras, et al.. (2024). Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry. Arthritis Research & Therapy. 26(1). 57–57. 3 indexed citations
7.
Hernández‐Cruz, Blanca, Manuel José Moreno Ramos, Juan María Blanco-Madrigal, et al.. (2024). Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry. Annals of the Rheumatic Diseases. 83(9). 1189–1199. 13 indexed citations
8.
Castañeda, Santos, Fernando Sánchez‐Alonso, Iván Ferraz‐Amaro, et al.. (2024). Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period. RMD Open. 10(2). e004207–e004207. 7 indexed citations
9.
Castañeda, Santos, Fernando Sánchez‐Alonso, Iván Ferraz‐Amaro, et al.. (2024). Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up. Seminars in Arthritis and Rheumatism. 66. 152442–152442. 4 indexed citations
10.
Hetland, Merete Lund, Axel Finckh, Jacques‐Eric Gottenberg, et al.. (2023). Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries. Arthritis Research & Therapy. 25(1). 101–101. 3 indexed citations
11.
Álvaro‐Gracia, José María, Carlos Sánchez‐Piedra, Dante R. Culqui, et al.. (2023). Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study. RMD Open. 9(1). e002936–e002936. 5 indexed citations
12.
Fernández‐Carballido, Cristina, Carlos Sánchez‐Piedra, Fernando Sánchez‐Alonso, et al.. (2022). Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence–Based Data Analyses of a National Multicenter Prospective Registry. Arthritis Care & Research. 75(1). 115–124. 11 indexed citations
13.
Torrente-Segarra, Vicenç, Hèctor Corominas, Carlos Sánchez‐Piedra, et al.. (2017). Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER).. PubMed. 35 Suppl 105(3). 28–34. 19 indexed citations
14.
Seoane‐Mato, Daniel, et al.. (2016). Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain. Rheumatology International. 36(11). 1525–1534. 3 indexed citations
15.
Sánchez‐Alonso, Fernando, et al.. (2013). Incidencia de VIH en personas que acuden a centros de diagnóstico de VIH/ITS: diferencias según mecanismo de transmisión (Estudio EPI-VIH). 1(1). 64–65. 1 indexed citations
16.
Sánchez‐Alonso, Fernando, et al.. (2006). Evolución de la razón de género en el consumo de drogas legales e ilegales en España. Boletín epidemiológico semanal. 14(10). 109–112. 2 indexed citations
17.
Castilla, Jesús, Isabel Noguer, María José Belza, et al.. (2002). ¿Estamos diagnosticando a tiempo a las personas infectadas por el VIH?. Atención Primaria. 29(1). 20–25. 13 indexed citations
18.
Sánchez‐Torres, Carmen, Nieves Doménech, Jesús Vázquez, et al.. (1999). The Porcine 2A10 Antigen Is Homologous to Human CD163 and Related to Macrophage Differentiation. The Journal of Immunology. 162(9). 5230–5237. 110 indexed citations
19.
Sánchez‐Alonso, Fernando, et al.. (1999). La anotación de los corpus CREA y CORDE. Procesamiento del lenguaje natural. 25(25). 175–182. 2 indexed citations
20.
Grandas, Francisco, et al.. (1998). Blink reflex recovery cycle in patients with blepharospasm unilaterally treated with botulinum toxin.. PubMed. 21(5). 307–11. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukië Tanaka Breakdown of academic impact, for papers by Monika Fijak Breakdown of academic impact, for papers by Ann Marie Bongiovanni Breakdown of academic impact, for papers by H. WORSAAE Breakdown of academic impact, for papers by Subbi Mathur Breakdown of academic impact, for papers by Sudhanshu Bhushan Breakdown of academic impact, for papers by Gudmund Marhaug Breakdown of academic impact, for papers by Ilkka Junttila Breakdown of academic impact, for papers by Guan K. Tay Breakdown of academic impact, for papers by Sylvette Bas
Rankless by CCL
2026